Buried Bumper Syndrome Clinical Trial
— ESCAPEOfficial title:
A Prospective Randomized Controlled Multicenter Trial for Evaluation of the Flamingo Device in Endoscopic Treatment of the Buried Bumper Syndrome.
| NCT number | NCT03186066 |
| Other study ID # | ESCAPE |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | June 2, 2017 |
| Est. completion date | April 8, 2023 |
| Verified date | March 2024 |
| Source | Kliniken Ludwigsburg-Bietigheim gGmbH |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Percutaneous endoscopic gastrostomy (PEG) is a method for nutrition delivery for patients with insufficient oral intake. A rare but severe complication of PEG is the Buried Bumper Syndrome (BBS). In BBS the internal fixation device of the PEG migrates along the stoma chanel. The internal fixation disc becomes covered by gastric mucosa, which causes loss of patency, fixation of the PEG and possible leakage around the PEG. BBS can be treated endoscopically by dissecting the overgrowing tissue with endoscopic submucosal dissection (ESD) knifes. A new and alternative approach is the use of the Flamingo device, which is inserted over the PEG and then is used to radially dissect the overgrowing tissue with a cutting wire. In this study both methods, the standard method using an ESD knife and the Flamingo device, are compared in a randomized controlled open-label trial. Primary endpoint is the time needed for PEG removal.
| Status | Completed |
| Enrollment | 52 |
| Est. completion date | April 8, 2023 |
| Est. primary completion date | September 30, 2022 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Endoscopy proven Buried Bumper Syndrome - PEG or Jet-PEG Exclusion Criteria: - Major Coagulation disorder - Percutaneous endoscopic jejunostomy or use of a ballon fixed device |
| Country | Name | City | State |
|---|---|---|---|
| Germany | Klinikum Ludwigsburg | Ludwigsburg |
| Lead Sponsor | Collaborator |
|---|---|
| Kliniken Ludwigsburg-Bietigheim gGmbH |
Germany,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Time for Removal of PEG | Assessed at day 1 (day of intervention) | ||
| Secondary | Success rate | Assessed at day 1 | ||
| Secondary | Complications | Assessed during follow-up for up to ten days |